Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients

Artificial Organs

Volumn 26, Issue 4, 2002, Pages 366-370

  Sezer, S ^a   Ozdemir F N ^a   Yakupoglu, U ^a   Arat, Z ^a   Turan, M ^a   Haberal, M ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Anemia; Ascorbic acid; Hemodialysis; Iron overload

Indexed keywords

ASCORBIC ACID; HEMODIALYZERS; IRON; PATIENT TREATMENT;

ANEMIA; CELL/B.E; HAEMATOCRIT; HAEMODIALYSIS; HAEMOGLOBINS; HEMODIALYSIS PATIENT; HUMAN ERYTHROPOIETIN; INITIAL PHASIS; IRON OVERLOADS; RED CELLS;

DIALYSIS;

ASCORBIC ACID; FERRITIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HUMAN; IRON OVERLOAD; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036239876     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2002.06888.x     Document Type: Article

References (16)

1. Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: Strategies for assessment and management
2. Erythropoietin treatment in haemodialysis patients with iron overload
3. Is there a role for adjuvant therapy in patients being treated with epoetin?
4. The effects of ascorbic acid on the intracellular metabolism of iron and ferritin
5. The role of ascorbic acid in the metabolism of storage iron
6. Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration
7. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis
8. Iron treatment: Impact of safety issues
9. NFK-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
10. Intravenous ascorbic acid as an adjuvant therapy for recombinant erytropoietin in hemodialysis patients with hyperferritinemia
11. Intravenous ascorbic acid in haemodialysis patients with functional iron deficiency
12. Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal
13. The effect of vitamin C intake on plasma oxalate in patients on regular haemodialysis
14. A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in haemodialysis patients with iron overload
15. Iron replacement in rHuEPO-treated dialysis patients. DOQI and beyond
16. The utility of zinc protoporphrin for predicting the need for intravenous iron therapy in hemodialysis patients